Explorer

Amazon, Flipkart Among 20 E-Tailers To Get DCGI Notice For Selling Drugs Without Licence

Drugs Controller General of India has issued show-cause notices to e-tailers Amazon and Flipkart Health plus and other 18 sellers over the online sale of drugs in violation of norms

E-tailers Amazon and Flipkart Health plus and other 18 sellers have received show-cause notices from the Drugs Controller General of India (DCGI) over the online sale of drugs in violation of norms.

DCGI VG Somani, who issued the show-cause notice on February 8, cited a Delhi High Court order dated December 12, 2018, which bans online sales of medicines without a licence, reported news agency PTI.

The notice also noted that the order was forwarded to all state and Union Territories in May by the drug controller and again in November 2019 and February 3 for necessary action and compliance.

READ: Aero India 2023 India To Fully Indigenise Tejas Fighter Jet Very Soon Defence Minister Rajnath Singh Atmanirbhar Scheme HAL (abplive.com)

"In spite of the same, you are found to be engaged in such activities without a licence," the notice sent to the online medicine sellers stressed, the report added.

"...You are hereby asked to show cause within 2 days from the date of issue of this notice, why action shall not be taken against you for sale, or stock, or exhibit or offer for sale or distribution of drugs in contravention of the provisions of the Drugs and Cosmetics Act 1940 and rules made thereunder," the notice said.

What’s Not Allowed?

The notice has categorically mentioned that any sale or stock or exhibit or offer for sale or distribution of any drug requires a licence from the concerned state licensing authority. Moreover, the conditions of a licence also need to be complied with by the licence holders.

The DCGI noted that in absence of any response, it will be understood that the company has nothing to say in the matter and necessary action will be initiated against them without any further notice.

Flipkart Health Plus confirmed receiving the notice and committed to complying with the laws. "We have received the notice from CDSCO (Central Drugs Standard Control Organisation) and are responding to it appropriately. As an organisation, we remain committed to complying with the laws of the land and towards continuous improvements of our processes/checks and controls on our marketplace platform to build trust and enhance customer experience," Flipkart Health Plus said.

Flipkart Health Plus added saying that it is a digital healthcare marketplace platform that enables easy and convenient access to genuine and affordable medicines and healthcare products, from independent sellers to millions of customers across the country.

View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headlines

Maharashtra Election Results: Eknath Shinde King Or Kingmaker? Shiv Sena Sources Say...
Maharashtra Results: Eknath Shinde King Or Kingmaker? Shiv Sena Sources Say...
Medicos Demand Rahul Gandhi's Apology Over 'Biden's Memory Loss' Remark While Mocking PM Modi
Medicos Demand Rahul Gandhi's Apology Over 'Biden's Memory Loss' Remark While Mocking PM Modi
Chhattisgarh: 10 Naxals Killed In Encounter With Security Forces In Sukma
Chhattisgarh: 10 Naxals Killed In Encounter With Security Forces In Sukma
High Alert In Sambhal Ahead Of Friday Prayers After Jama Masjid Survey
High Alert In Sambhal Ahead Of Friday Prayers After Jama Masjid Survey
Advertisement
ABP Premium

Videos

India Emerges as G20's Growth Leader, Check Out the Latest GDP Rankings | ABP NewsAirtel-Nokia Partnership: Nokia’s Spectacular Comeback, Shakes Up the Telecom Sector | ABP NewsAdani Group in Turmoil: Bribery Scandal Rocks Shares, Plunge by 20% | ABP NewsPLI Scheme: Transforming India's Manufacturing Sector into a Global Powerhouse

Photo Gallery

Embed widget